Engineering polymeric microparticles as theranostic carriers for selective delivery and cancer therapy

Adv Healthc Mater. 2013 Dec;2(12):1571-5. doi: 10.1002/adhm.201300077. Epub 2013 May 28.

Abstract

Multifunctional polymeric nano- and microparticles are engineered as theranostic carriers and their selective size-dependent cellular uptake is demonstrated. It is found that effective uptake and accumulation of nanoparticles occurs in both normal and cancer cells, whereas, that of microparticles occurs in cancer cells but not in normal cells, allowing cancer cells to be specifically targeted for local drug delivery.

Keywords: cancer therapy; microparticles; nanoparticles; selective uptake.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology
  • Camptothecin / chemistry
  • Camptothecin / pharmacokinetics
  • Camptothecin / pharmacology
  • Cell Line
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Carriers / chemistry*
  • Drug Carriers / pharmacokinetics
  • Drug Carriers / pharmacology
  • Humans
  • Lactic Acid / chemistry*
  • Lactic Acid / pharmacokinetics
  • Lactic Acid / pharmacology
  • Microspheres
  • Nanoparticles / chemistry
  • Polyglycolic Acid / chemistry*
  • Polyglycolic Acid / pharmacokinetics
  • Polyglycolic Acid / pharmacology
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Quantum Dots*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Camptothecin